West Lafayette, IN, United States of America

Petinka I Vlahova

USPTO Granted Patents = 25 (Patent Applications = 9)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 92(Granted Patents)

Company Filing History:

9 out of 63

Salix Pharmaceuticals, Inc.

patents

7 out of 1,153

Vertex Pharmaceuticals, Inc.

patents

5 out of 40

Biomed Valley Discoveries, Inc.

patents

4. 3 out of 3,685

Bristol-Myers Squibb Compnay

Gi Therapeutics, Inc.

patents

7. 1 out of 48

G1 Therapeutics, Inc.

patents

8. 1 out of 6

Sumitomo Pharma Switzerland Gmbh

patents

9. 1 out of 1,179

Takeda Pharmaceutical Company Limited

patents

10. 1 out of 924

Gilead Sciences, Inc.

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421195 - Amorphous and crystalline forms of IDO inhibitors (2025-09-23),

2. 12338249 - Crystalline forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea (2025-06-24),

3. 12187698 - Crystalline forms of CHClNO (2025-01-07),

4. 12139494 - Morphic forms of G1T38 and methods of manufacture thereof (2024-11-12),

5. 12129264 - Crystalline forms of a PAR4 inhibitor (2024-10-29),

6. 11390600 - Crystalline forms of CHClNO (2022-07-19),

7. 11261193 - Morphic forms of G1T38 and methods of manufacture thereof (2022-03-01),

8. 11236049 - Amorphous and crystalline forms of IDO inhibitors (2022-02-01),

9. 10738027 - Crystalline forms of CHClNO (2020-08-11),

10. 10183927 - [object Object] (2019-01-22),

11. 9676746 - [object Object] (2017-06-13),

12. 9546183 - Forms of rifaximin and uses thereof (2017-01-17),

13. 9273066 - Forms of rifaximin and uses thereof (2016-03-01),

14. 9273038 - Solid forms of an ion channel modulator (2016-03-01),

15. 9120766 - Methods of making cocrystals (2015-09-01),

Title: The Inventor Spotlight: Petinka I Vlahova

Introduction:

Petinka I Vlahova is a talented inventor based in West Lafayette, IN (US) who has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 20 patents, she continues to drive innovation in the treatment of cancer and beyond.

Latest Patents:

Among Vlahova's latest patents are crystalline forms of CHClNO, a compound with great potential for the treatment of cancer. Additionally, her work on morphic forms of G1T38 showcases her dedication to improving therapeutic pharmaceutical efficacy and dosage form stability.

Career Highlights:

Vlahova has honed her expertise through her tenure at reputable companies such as Salix Pharmaceuticals, Inc. and Vertex Pharmaceuticals, Inc. Her experience in these esteemed organizations has further fueled her passion for research and development in the pharmaceutical industry.

Collaborations:

Throughout her career, Vlahova has had the privilege of collaborating with accomplished professionals in the field. Some of her notable coworkers include Karen Sue Gushurst and Donglai Yang, who have contributed to the success of various projects alongside Vlahova.

Conclusion:

In conclusion, Petinka I Vlahova stands out as a prominent figure in the world of pharmaceutical innovation. Her dedication to advancing treatment options for cancer patients is reflected in her impressive patent portfolio and successful collaborations. Vlahova's work serves as a testament to the impact that inventive minds can have on improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.